Lorlatinib (Lorbrena)

lorlatinib · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lorlatinib (Lorbrena), covering 2025-12-23 to 2025-12-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Cancer [Phase 2]